Cargando…
Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications
FLT3 is a type III receptor tyrosine kinase. Mutations of FLT3 comprise one of the most frequently identified types of genetic alterations in acute myeloid leukemia. One-third of acute myeloid leukemia patients have mutations of this gene, and the majority of these mutations involve an internal tand...
Autor principal: | Takahashi, Shinichiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076284/ https://www.ncbi.nlm.nih.gov/pubmed/21453545 http://dx.doi.org/10.1186/1756-8722-4-13 |
Ejemplares similares
-
FLT3 Mutations in Acute Myeloid Leukemia: Unraveling the Molecular Mechanisms and Implications for Targeted Therapies
por: Jalte, Meryem, et al.
Publicado: (2023) -
FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018) -
Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
por: Gebru, Melat T., et al.
Publicado: (2020) -
Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling
por: Takahashi, Shinichiro
Publicado: (2019) -
Targeting FLT3 Mutations in Acute Myeloid Leukemia
por: El Fakih, Riad, et al.
Publicado: (2018)